Omnitus syrup 0.8 mg / ml fl. 200ml

Transparent, colorless or with a yellowish tinge, viscous liquid with a vanilla smell.

Pharmaco-therapeutic group

N4 Dry cough of any etiology (for colds, flu, whooping cough and other conditions).

Suppression of cough in the preoperative and postoperative period, during surgery, bronchoscopy.

Application during pregnancy and during breastfeeding

There is no data on the safety of using the drug during pregnancy and its passage through the placental barrier.

The use of the drug in the first trimester of pregnancy is contraindicated.

In the II and III trimesters of pregnancy, the use of the drug is possible if the expected benefit to the mother outweighs the potential risk to the fetus.

It is not known whether the active substance of the drug or its metabolites penetrates into breast milk, therefore, the use of the drug during breastfeeding is not recommended.

Dosage form

Syrup 0.8 mg / ml.

200 ml of the drug in a dark glass bottle of hydrolytic group III, sealed with a polyethylene lid with control of the first opening.

On the top side of the cap there is a diagram of the bottle opening.

1 bottle together with a measuring spoon made of polypropylene (5 ml volume, with a line for 2.5 ml volume) and with instructions for medical use of the medicinal product in a cardboard box.

Shelf life

5 years.

Do not use after the expiration date printed on the package.

Category

Symptomatic drugs

Name ENG

OMNITUS

Clinical and pharmacological group

Antitussive drug

ATX code

Butamirate

Dosage

0.8mg / ml x 200ml

Structure

One milliliter of the preparation contains: active ingredient - butamirate citrate - 0.8 mg

auxiliary substances: sorbitol 70% (non-crystallizing), glycerol, sodium saccharin, benzoic acid, vanillin, anise oil, ethanol 96%, sodium hydroxide, purified water.

Indications

dry cough of any etiology (with colds, flu, whooping cough and other conditions)

to suppress cough in the preoperative and postoperative period, during surgical interventions, bronchoscopy.

Contraindications

Hypersensitivity to the components of the drug, pregnancy (I trimester), breastfeeding, children under 3 years of age.

Fructose intolerance (the drug contains sorbitol).

INN / Active ingredient

Butamirat

Storage conditions and periods

At a temperature not exceeding 25 ° С in consumer packaging.

After opening, store the bottle in the consumer packaging at a temperature of 15 to 25 ° C and use until the expiration date.

Keep out of the reach of children.

Specifications

Category

Cough

Scope of the medicinal product

Respiratory system

Release form

Syrup

Manufacturer country

Serbia

Scope of application

Virology

Minimum age from

3 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Volume, ml.

200 ml

Brand name

Hemofarm

Components

measuring spoon

The amount of the dosage form in the primary package

200 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Central antitussive agent

Anatomical and therapeutic characteristics

R05DB13 Butamirate

Dosage form

Syrup

Expiration date in days

1825

Dosage (volume) of the substance in the preparation

0.8 mg / ml

Package weight, g

300

Mode of application

:

Inside, before meals.

The syrup contains 1 scoop (5 ml): Children: from 3 to 6 years (15-22 kg) - 2 scoops (10 ml) 3 times a day from 6 to 9 years (22-30 kg) - 3 scoops (15 ml) 3 times a day over 9 years old (40 kg) - 3 scoops (15 ml) 4 times a day Adults: - 6 scoops (30 ml) 3 times a day If the cough persists for more than 5 days after starting treatment, you should consult a doctor.

Instructions for opening the bottle The bottle is closed with a lid with a safety device that prevents children from opening it.

In order to open the bottle, you need to firmly press on the top of the cap and turn it counterclockwise.

After use, the bottle must be tightly closed for this, the bottle cap must be tightened again.